Oxazinanes
Aobchem (3 4-Dichlorophenyl)(morpholino)methanone | 95% | CAS 33764-00-0 | C11H11Cl2NO2 | 1g
(3 4-Dichlorophenyl)(morpholino)methanone | 95% | CAS 33764-00-0 | C11H11Cl2NO2 | 1g
Aobchem 2-(4-Chlorophenyl)-1-morpholinoethanone | 95% | CAS 99931-95-0 | C12H14ClNO2 | 5g
2-(4-Chlorophenyl)-1-morpholinoethanone | 95% | CAS 99931-95-0 | C12H14ClNO2 | 5g
Aobchem (3-Chloro-4-cyanophenyl)boronic acid | ≥95% | CAS 1008415-02-8 | C7H5BClNO2 | 250mg
(3-Chloro-4-cyanophenyl)boronic acid | ≥95% | CAS 1008415-02-8 | C7H5BClNO2 | 250mg
Aobchem (3-Chloro-4-cyanophenyl)boronic acid | ≥95% | CAS 1008415-02-8 | C7H5BClNO2 | 500mg
(3-Chloro-4-cyanophenyl)boronic acid | ≥95% | CAS 1008415-02-8 | C7H5BClNO2 | 500mg
Selleck Chemical LLC Tenofovir alafenamide hemifumarate S4427-25mg
Tenofovir alafenamide (TAF GS-7340) hemifumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection
Aobchem (3-Chloro-4-cyanophenyl)boronic acid | ≥95% | CAS 1008415-02-8 | C7H5BClNO2 | 10g
(3-Chloro-4-cyanophenyl)boronic acid | ≥95% | CAS 1008415-02-8 | C7H5BClNO2 | 10g
Aobchem 2 3-Dihydro-N-(phenylmethyl)-1 4-benzodioxin-6-sulfonamide | 95% | CAS 357159-16-1 | C15H15NO4S | 500mg
2 3-Dihydro-N-(phenylmethyl)-1 4-benzodioxin-6-sulfonamide | 95% | CAS 357159-16-1 | C15H15NO4S | 500mg
Aobchem (3-Acetyl-5-bromophenyl)boronic acid | 95% | CAS 2649459-72-1 | C8H8BBrO3 | 5g
(3-Acetyl-5-bromophenyl)boronic acid | 95% | CAS 2649459-72-1 | C8H8BBrO3 | 5g
Aobchem 2 3-Dihydro-N-(phenylmethyl)-1 4-benzodioxin-6-sulfonamide | 95% | CAS 357159-16-1 | C15H15NO4S | 1g
2 3-Dihydro-N-(phenylmethyl)-1 4-benzodioxin-6-sulfonamide | 95% | CAS 357159-16-1 | C15H15NO4S | 1g
Aobchem (3-Acetyl-5-bromophenyl)boronic acid | 95% | CAS 2649459-72-1 | C8H8BBrO3 | 1g
(3-Acetyl-5-bromophenyl)boronic acid | 95% | CAS 2649459-72-1 | C8H8BBrO3 | 1g